New HIV data, released today by the Kirby Institute at UNSW Sydney for World AIDS Day, are a reminder for Australia to sustain its efforts in HIV prevention amidst the COVID-19 pandemic.
A global-first, UNSW-led trial of an HIV prevention medication has resulted in an almost one-third decline in infections in the large-scale target group.
NSW is on track to virtually eliminate HIV transmission by 2020 as an expanded PrEP trial, led by the Kirby Institute at UNSW, enrols its one thousandth participant in record time.
A landmark clinical trial led by UNSW researchers aims to halve new HIV infections in NSW within two years and 'virtually eliminate' HIV transmission by 2020.